Eloxx Pharmaceuticals, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2010 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Eloxx Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to 2022.
  • Eloxx Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2023 was $418K, a 41.5% decline year-over-year.
  • Eloxx Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2023 was $2.4M, a 25.9% decline year-over-year.
  • Eloxx Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $3.02M, a 67% decline from 2021.
  • Eloxx Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $9.17M, a 5.78% increase from 2020.
  • Eloxx Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $8.67M, a 23.6% decline from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $3.02M -$6.15M -67% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-31
2021 $9.17M +$501K +5.78% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $8.67M -$2.67M -23.6% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 $11.3M -$2.03M -15.2% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-30
2018 $13.4M +$13.3M +13138% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-12
2017 $101K +$23K +29.5% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-06
2016 $78K -$14K -15.2% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-14
2015 $92K -$1.21M -92.9% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-16
2014 $1.3M +$573K +79% Jul 1, 2013 Jun 30, 2014 10-K 2016-10-13
2013 $725K -$41.3K -5.39% Jul 1, 2012 Jun 30, 2013 10-K 2015-10-09
2012 $766K +$15.6K +2.08% Jul 1, 2011 Jun 30, 2012 10-K 2014-09-29
2011 $750K +$310K +70.4% Jul 1, 2010 Jun 30, 2011 10-K 2013-09-11
2010 $440K Jul 1, 2009 Jun 30, 2010 10-K/A 2012-10-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.